As of December 15, 2025, Patient Access Solutions Inc (PASO) reports a ROE (Return on Equity) of -3.90%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Patient Access Solutions Inc's ROE (Return on Equity)
Over recent years, Patient Access Solutions Inc's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2010-10-31 | -3.90% |
| 2009-10-31 | 833.92% |
| 2008-10-31 | 450.83% |
| 2007-10-31 | -3.90% |
This slight upward trend highlights how Patient Access Solutions Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Patient Access Solutions Inc's ROE (Return on Equity) to Peers
To better understand Patient Access Solutions Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Patient Access Solutions Inc (PASO) | -3.90% |
| Virpax Pharmaceuticals Inc (VRPX) | 1320.61% |
| Apotheca Biosciences Inc (CBDC) | 307.69% |
| Greengro Technologies Inc (GRNH) | 291.79% |
| TGI Solar Power Group Inc (TSPG) | 248.62% |
| Plurilock Security Inc (PLUR.V) | 224.31% |
Compared to its competitors, Patient Access Solutions Inc's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.